Tech Company Financing Transactions
Cascade Biocatalysts Funding Round
Cascade Biocatalysts closed a $2.6 million Seed funding round on 8/22/2023. Investors included Ten VC, Amplify.LA and Boost VC.
Transaction Overview
Company Name
Announced On
8/22/2023
Transaction Type
Venture Equity
Amount
$2,600,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to scale its impact from the lab bench to pilot scale and to support its initial wave of customers.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Denver, CO 80221
USA
Denver, CO 80221
USA
Phone
Undisclosed
Website
Email Address
Overview
Cascade Biocatalysts is creating more productive enzymes for economical biomanufacturing of sustainable chemicals. Cascade addresses the growing need for stable, long-lasting biocatalysts using our patent-pending enzyme immobilization platform. By combining nature's catalyst, enzymes, with state-of-the-art materials, we can create something that is greater than the sum of its parts. Join us as we help build the future bioeconomy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Rosay
Co-Founder
James Weltz
Browse more venture capital transactions:
Prev: 8/22/2023: ScribeUp venture capital transaction
Next: 8/22/2023: Northvolt venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs